Page last updated: 2024-08-22

trimetazidine and Adenocarcinoma, Bronchiolo-Alveolar

trimetazidine has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altuwaijri, S; Andela, VB; Rosier, RN; Wood, J1

Other Studies

1 other study(ies) available for trimetazidine and Adenocarcinoma, Bronchiolo-Alveolar

ArticleYear
Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists.
    FEBS letters, 2005, Mar-14, Volume: 579, Issue:7

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Chromans; Coenzyme A Ligases; Fatty Acid Synthases; Fatty Acids; Gene Expression; Glucose; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxidation-Reduction; Oxygen Consumption; PPAR gamma; Thiazolidinediones; Trimetazidine; Troglitazone

2005